Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition

Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has closed the acquisition…

Algernon closes NoBrainer acquisition

Algernon Pharmaceuticals (CSE:AGN) has officially closed its acquisition of NoBrainer Imaging Centres, Inc., marking a significant expansion into the Alzheimer’s Disease diagnostic and treatment market Algernon issued 5.5 million common shares and 5.5 million common share purchase warrants NoBrainer brings with it C$250,000 in working capital and a deposit on a Positrigo NeuroLF PET scanner Algernon Pharmaceuticals stock (CSE:AGN) last traded at…